Owens & minor reports 1st quarter 2018
financial results
Richmond, va.--(business wire)--owens & minor, inc. (nyse: omi) today reported financial results for the first quarter ended march 31, 2018, including consolidated revenues of $2.37 billion, representing an increase of 1.9%, when compared to revenues of $2.33 billion in the first quarter of 2017. quarterly net income was $8.2 million compared to $18.8 million, or $0.13 per diluted share, compared to $0.31 for the first quarter of last year. adjusted net income (non-gaap) was $26.2 million compared to $26.4 million, or $0.43 per share, compared to $0.44 per share in last year’s first quarter. a reconciliation of reported results to adjusted (non-gaap) measures is included below. consolidated operating income for the first quarter of 2018 was $24.2 million compared to $35.5 million in last year’s first quarter. adjusted consolidated operating income (non-gaap) for the first quarter was $47.6 million compared to $47.7 million for the same period last year. “we are pleased to have completed the acquisition of halyard health’s s&ip business, which represents a meaningful step in the evolution of our business. together, the halyard s&ip business and byram healthcare serve to strengthen and diversify our business model,” said p. cody phipps, chairman, president & chief executive officer of owens & minor. “our quarterly results improved sequentially, consistent with our expectations, as we continued to transform our business. by combining the halyard s&ip business with our existing products group, our global products strategic business unit has an enhanced presence in the medical products sector with approximately $1.5 billion in annualized revenues. this transaction gives owens & minor a global platform for growth with a strong product portfolio and exceptional teammates.” acquisition of halyard health s&ip business on april 30, 2018, the company completed the acquisition of halyard health’s s&ip business. halyard s&ip’s highly regarded surgical and infection prevention offerings range from sterilization wraps, surgical drapes and gowns, facial protection and protective apparel to medical exam gloves and include brands such as aeroblue and aerochrome; exam gloves including purple, lavender and sterling; and sterilization wraps such as one-step, quick check and smart-fold. this business will become an essential part of the global products strategic business unit. with access to markets in 90 countries, the halyard s&ip business provides owens & minor with global reach and a platform for growth. to finance the transaction, owens & minor entered into new, multi-year term loan agreements with banks and institutional lenders. segment results owens & minor is now operating under two strategic business units (sbus)—global solutions and global products—reflecting the company’s evolving business. management believes the new sbu structure will create better alignment within the organization. results for these two new segments include the following: the global solutions sbu is comprised of the former domestic and international segments, which includes our u.s. and european distribution, logistics and value-added services business, as well as byram healthcare. revenues for the first quarter of 2018 were $2.34 billion compared to $2.29 billion a year ago. global solutions’ operating income was $31.6 million compared to $38.0 million a year ago, as a result of continued margin pressure and warehouse inefficiencies in our distribution centers. teams are actively working to resolve the inefficiencies. byram healthcare, acquired in august 2017, contributed positively to quarterly results, adding $118 million to revenues. byram is bringing significant momentum to owens & minor’s strategy to serve the market along the continuum of care. the global products sbu is comprised of our former proprietary products segment, which includes global sourcing, clinical & procedural solutions (cps), and now the halyard s&ip business. revenues in the first quarter of 2018 were $121 million compared to $137 million for the same period last year. because the acquisition was completed on april 30, 2018, global products first quarter results do not reflect contributions from halyard s&ip revenues. the quarterly revenue change resulted primarily from the previously discussed loss of customers last year. however, global products’ operating income increased by $1.7 million to $9.8 million, as a result of improved operating efficiencies. asset management the balance of cash and cash equivalents was $87.6 million at march 31, 2018, compared to $105 million at december 31, 2017. for the quarter, the company reported operating cash flow of $18.3 million, compared to a use of cash of $26.4 million for the same period last year. for the quarter, asset management metrics included consolidated days sales outstanding (dso) of 28.9 compared to 28.7 days as of year-end. consolidated inventory turns were 8.3 times for the first quarter, compared to 8.5 times in 2017. upcoming investor events owens & minor plans to participate in the following investor conferences in the second quarter of 2018 and the company will post webcasts of formal presentations on its corporate website: bank of america merrill lynch 2018 healthcare conference; may 15 goldman sachs 2018 global healthcare conference; june 12 investors conference call & supplemental material conference call: owens & minor will conduct a conference call for investors on thursday, may 10, 2018, at 8:30 a.m. edt. the access code for the conference call, international dial-in and replay is #5037238. participants may access the call at 866-393-1604. the international dial-in number is 224-357-2191. replay: a replay of the call will be available for one week by dialing 855-859-2056. webcast: a listen-only webcast of the call, along with supplemental information, will be available on www.owens-minor.com under the investor relations section. safe harbor statement this release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the sec's fair disclosure regulation. this release contains certain ''forward-looking'' statements made pursuant to the safe harbor provisions of the private securities litigation reform act of 1995. these statements include, but are not limited to, statements related to the company’s expectations regarding the performance of its business, growth, and the performance of the recently acquired halyard s&ip business. forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. investors should refer to owens & minor’s annual report on form 10-k for the year ended december 31, 2017, filed with the sec including in the sections captioned “cautionary note regarding forward-looking statements” and “item 1a. risk factors,” and subsequent quarterly reports on form 10-q and current reports on form 8-k filed with or furnished to the sec, for a discussion of certain other known risk factors that could cause our actual results to differ materially from our current estimates. these filings are available at www.owens-minor.com. given these risks and uncertainties, we can give no assurance that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. we specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. owens & minor uses its web site, www.owens-minor.com, as a channel of distribution for material company information, including news releases, investor presentations and financial information. this information is routinely posted and accessible under the investor relations section. included with the press release financial tables are reconciliations of the differences between the non-gaap financial measures presented in this news release, which exclude acquisition-related and exit and realignment charges, and their most directly comparable gaap financial measures. about owens & minor owens & minor, inc. (nyse: omi) is a global healthcare solutions company with integrated technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. with 17,000 dedicated teammates serving healthcare industry customers in 90 countries, owens & minor helps to reduce total costs across the supply chain by optimizing episode and point-of-care performance, freeing up capital and clinical resources, and managing contracts to optimize financial performance. a fortune 500 company, owens & minor has annualized revenues exceeding $10 billion, including contributions from halyard health s&ip. founded in 1882, owens & minor has operated continuously from its richmond, virginia, headquarters. today, the company now has distribution, production, customer service and sales facilities located across asia, europe, latin america, and the u.s. for more information about owens & minor, visit owens-minor.com, follow @owens_minor on twitter, and connect on linkedin at www.linkedin.com/company/owens-&-minor. (dollars in thousands, except per share data) (dollars in thousands) (dollars in thousands) (dollars in thousands) (1) software as a service (saas) implementation costs associated with significant global it platforms in connection with the redesign of our global information system strategy. (dollars in thousands, except per share data) (dollars in thousands, except per share data) the following items in the current quarter have been excluded in our non-gaap financial measures: (1) acquisition-related intangible amortization includes amortization of certain intangible assets established during purchase accounting for business combinations. these amounts are highly dependent on the size and frequency of acquisitions and are being excluded to allow for a more consistent comparison with forecasted, current and historical results and the results of our peers. we began to exclude these charges from our non-gaap results in the second quarter of 2017 and thus prior year amounts have been recast on the same basis. (2)acquisition related expenses in the current quarter consist primarily of transition and transaction costs for the halyard s&ip transaction and byram and in first quarter of 2017 consist primarily of transition and transaction costs for byram. (3) exit and realignment charges in 2018 were primarily associated with establishment of our client engagement center. amounts in 2017 were associated with the write-down of information system assets which are no longer used and severance charges from reduction in force and other employee costs associated with the establishment of our new client engagement center. (4) software as a service (saas) implementation costs associated with the upgrading of global it platforms in connection with the redesign of our global information system strategy. saas implementation costs are recorded in other operating (income) expense, net. (5)these charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes. use of non-gaap measures
